GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (LTS:0QXX) » Definitions » Sale Of Business

Molecular Partners AG (LTS:0QXX) Sale Of Business : CHF0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Molecular Partners AG Sale Of Business?

Molecular Partners AG's sale of business for the three months ended in Dec. 2024 was CHF0.00 Mil. It means Molecular Partners AG gained CHF0.00 Mil from selling business. Molecular Partners AG's sale of business for the trailing twelve months (TTM) ended in Dec. 2024 was CHF0.00 Mil.

Compared with last quarter (CHF0.00 Mil in Sep. 2024 ), Molecular Partners AG gained the same money from selling business in Dec. 2024 (CHF0.00 Mil).


Molecular Partners AG Sale Of Business Historical Data

The historical data trend for Molecular Partners AG's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Partners AG Sale Of Business Chart

Molecular Partners AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Molecular Partners AG Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Molecular Partners AG Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molecular Partners AG Sale Of Business Related Terms

Thank you for viewing the detailed overview of Molecular Partners AG's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Partners AG Business Description

Address
Wagistrasse 14, Schlieren, Zurich, CHE, 8952
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Molecular Partners AG Headlines

No Headlines